F.D.A. Approves New Obesity Drug That Will Compete With Wegovy - The New York Times
- F.D.A. Approves New Obesity Drug That Will Compete With Wegovy The New York Times
- FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new name, Zepbound CNN
- FDA approves Mounjaro for weight loss FOX 32 Chicago
- FDA approves Eli Lilly's tirzepatide for weight loss, paving way for wider use of blockbuster drug CNBC
- View Full Coverage on Google News